Systemic Corticosteroids and the Risk of Venous Thromboembolism in Patients with Severe COPD: A Nationwide Study of 30,473 Outpatients
暂无分享,去创建一个
T. Biering-Sørensen | N. Seersholm | F. Knop | O. Hilberg | A. Løkke | C. Laursen | J. Carlsen | P. Sivapalan | Jens-Ulrik Stæhr Jensen | J. Eklöf | U. Bødtger | N. Godtfredsen | Vibeke Gottlieb | H. Priemé | T. Ingebrigtsen | H. Meteran | Mohamad Isam Saeed | J. Janner | J. Wilcke | L. Tønnesen | Alexandra S. Jordan | Ema Rastoder | Thyge Lynghøj Nielsen | J. Stæhr Jensen | M. I. Saeed | E. Rastoder | A. Jordan
[1] C. Tromeur,et al. Prevalence of Pulmonary Embolism Among Patients With COPD Hospitalized With Acutely Worsening Respiratory Symptoms. , 2021, JAMA.
[2] T. Biering-Sørensen,et al. Use of inhaled corticosteroids and the risk of developing type 2 diabetes in patients with chronic obstructive pulmonary disease , 2020, Diabetes, obesity & metabolism.
[3] W. Mack,et al. Venous Thromboembolism After Degenerative Spine Surgery: A Nationwide Readmissions Database Analysis. , 2019, World neurosurgery.
[4] N. Seersholm,et al. COPD exacerbations: the impact of long versus short courses of oral corticosteroids on mortality and pneumonia: nationwide data on 67 000 patients with COPD followed for 12 months , 2019, BMJ Open Respiratory Research.
[5] C. Sabapathy,et al. Risk factors for post-discharge venous thromboembolism in patients undergoing colorectal resection: a NSQIP analysis , 2018, Techniques in Coloproctology.
[6] J. Pines,et al. Pulmonary Embolism Among Patients With Acute Exacerbation Of Chronic Obstructive Pulmonary Disease: Implications For Emergency Medicine. , 2018, The Journal of emergency medicine.
[7] M. Rogers,et al. Short term use of oral corticosteroids and related harms among adults in the United States: population based cohort study , 2017, British Medical Journal.
[8] Q. de Mast,et al. Prevalence and Localization of Pulmonary Embolism in Unexplained Acute Exacerbations of COPD: A Systematic Review and Meta‐analysis , 2017, Chest.
[9] J. Sundquist,et al. Risk of pulmonary embolism and deep venous thrombosis in patients with asthma: a nationwide case−control study from Sweden , 2017, European Respiratory Journal.
[10] P. Lange,et al. Danish Register of chronic obstructive pulmonary disease , 2016, Clinical epidemiology.
[11] T. van der Poll,et al. UvA-DARE ( Digital Academic Repository ) Asthma and coagulation : A clinical and pathophysiological evaluation , 2016 .
[12] E. Connolly,et al. Association of Steroid Use with Deep Venous Thrombosis and Pulmonary Embolism in Neurosurgical Patients: A National Database Analysis. , 2016, World neurosurgery.
[13] Sigrun Alba Johannesdottir Schmidt,et al. The Danish National Patient Registry: a review of content, data quality, and research potential , 2015, Clinical epidemiology.
[14] Rami S. Kantar,et al. Venous thromboembolism and preoperative steroid use: analysis of the NSQIP database to evaluate risk in surgical patients. , 2015, European journal of internal medicine.
[15] V. Kim,et al. Risk Factors for Venous Thromboembolism in Chronic Obstructive Pulmonary Disease. , 2014, Chronic obstructive pulmonary diseases.
[16] J. Torres-Macho,et al. Clinical features of patients inappropriately undiagnosed of pulmonary embolism. , 2013, The American journal of emergency medicine.
[17] N. Bateman. Use of glucocorticoids and risk of venous thromboembolism: a nationwide population‐based case–control study , 2013 .
[18] M. Briel,et al. Short-term vs conventional glucocorticoid therapy in acute exacerbations of chronic obstructive pulmonary disease: the REDUCE randomized clinical trial. , 2013, JAMA.
[19] E. Horváth-Puhó,et al. Use of glucocorticoids and risk of venous thromboembolism: a nationwide population-based case-control study. , 2013, JAMA internal medicine.
[20] P. Souverein,et al. Use of oral glucocorticoids and the risk of pulmonary embolism: a population-based case-control study. , 2013, Chest.
[21] A. Zwinderman,et al. Risk of deep vein thrombosis and pulmonary embolism in asthma , 2012, European Respiratory Journal.
[22] Henrik Toft Sørensen,et al. Existing data sources for clinical epidemiology: The Danish National Database of Reimbursed Prescriptions , 2012, Clinical epidemiology.
[23] C. Bédard,et al. Effect of prednisone administration on coagulation variables in healthy Beagle dogs. , 2011, Veterinary clinical pathology.
[24] L. Bertoletti,et al. Clinical presentation and outcome of venous thromboembolism in COPD , 2011, European Respiratory Journal.
[25] H. Gunen,et al. Venous thromboemboli and exacerbations of COPD , 2009, European Respiratory Journal.
[26] O. Gajic,et al. A postmortem analysis of major causes of early death in patients hospitalized with COPD exacerbation. , 2009, Chest.
[27] D. Sin,et al. Prevalence of pulmonary embolism in acute exacerbations of COPD: a systematic review and metaanalysis. , 2009, Chest.
[28] C. Huerta,et al. Risk factors and short-term mortality of venous thromboembolism diagnosed in the primary care setting in the United Kingdom. , 2007, Archives of internal medicine.
[29] D. Jiménez,et al. Pulmonary embolism in patients with chronic obstructive pulmonary disease or congestive heart failure. , 2006, The American journal of medicine.
[30] C. Marquette,et al. Pulmonary Embolism in Patients with Unexplained Exacerbation of Chronic Obstructive Pulmonary Disease: Prevalence and Risk Factors , 2006, Annals of Internal Medicine.
[31] R. Pauwels,et al. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease: GOLD Executive Summary Updated 2003 , 2004, COPD.
[32] J. T. Owings,et al. Biochemical basis for the hypercoagulable state seen in Cushing syndrome; discussion 1006-7. , 2001, Archives of surgery.
[33] B. Grant,et al. Clinical suspicion of fatal pulmonary embolism. , 2001, Chest.